Long-Term Outcomes of Robot-Assisted Radical Cystectomy: A Real-World Study

Not yet recruiting

• Conditions: Bladder Cancer; Robot-assisted Radical Cystectomy

• Registration Number: NCT05856825
• Lead Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Brief Summary

A multicenter, retrospective research was conducted. Patients who underwent robot-assisted radical cystectomy (RARC) from for bladder cancer in 32 institutions in China were enrolled in this study. Baseline condition, perioperative, pathological, and survival outcome were collected. The study was aimed to report the real-world condition of RARC in China, and evaluate its effectiveness.

Detailed Description

Not available

Study Timeline

• Status Verified: 2023-05
• Study Start: 2023-05-01
• Study First Submitted: 2023-05-04
• Study First Submitted QC: 2023-05-04
• Last Update Submitted: 2023-05-04
• Study First Posted: 2023-05-12
• Last Update Posted: 2023-05-12
• Primary Completion: 2023-12-31
• Study Completion: 2023-12-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 4500

Inclusion Criteria

• >18 years old; Clinical stage Ta-T4a/N0-3/M0.

Exclusion Criteria

• Severe cardiovascular disease; history of previous major abdominopelvic surgery; patients with distant metastases; medical history of malignancy in other organs.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cancer-specific survival	Five years	Time from date of surgery to death due to bladder cancer
Recurrence-free survival	Five years	Time from surgery to tumor recurrence which identified either pathologically or radiographically
Overall survival	Five years	Time from surgery until death from any cause